Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions.

Heinlein CA, Chang C.

Mol Endocrinol. 2002 Oct;16(10):2181-7. Review.

PMID:
12351684
2.

Rapid actions of androgens.

Michels G, Hoppe UC.

Front Neuroendocrinol. 2008 May;29(2):182-98. Epub 2007 Oct 5. Review.

PMID:
17983646
3.

Nongenomic actions of androgen in Sertoli cells.

Walker WH.

Curr Top Dev Biol. 2003;56:25-53. Review.

PMID:
14584725
4.

Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells.

Gatson JW, Kaur P, Singh M.

Endocrinology. 2006 Apr;147(4):2028-34. Epub 2006 Jan 12. Erratum in: Endocrinology. 2008 Jan;149(1):366.

PMID:
16410299
5.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

6.

Molecular mechanisms of androgen action.

Lindzey J, Kumar MV, Grossman M, Young C, Tindall DJ.

Vitam Horm. 1994;49:383-432. Review.

PMID:
7810074
7.

Non-genomic actions of androgens.

Foradori CD, Weiser MJ, Handa RJ.

Front Neuroendocrinol. 2008 May;29(2):169-81. Epub 2007 Nov 7. Review.

8.

Mechanisms and clinical relevance of androgens and androgen receptor actions.

Kang HY, Tsai MY, Chang C, Huang KE.

Chang Gung Med J. 2003 Jun;26(6):388-402. Review.

10.

Androgen receptor corepressors: an overview.

Wang L, Hsu CL, Chang C.

Prostate. 2005 May 1;63(2):117-30. Review.

PMID:
15486994
11.

Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands.

Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR.

Mol Endocrinol. 2003 Jun;17(6):1106-16. Epub 2003 Mar 13.

PMID:
12637588
12.

Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells.

Baron S, Manin M, Beaudoin C, Leotoing L, Communal Y, Veyssiere G, Morel L.

J Biol Chem. 2004 Apr 9;279(15):14579-86. Epub 2003 Dec 10.

13.

The androgen receptor (AR) amino-terminus imposes androgen-specific regulation of AR gene expression via an exonic enhancer.

Grad JM, Lyons LS, Robins DM, Burnstein KL.

Endocrinology. 2001 Mar;142(3):1107-16.

PMID:
11181525
15.

[Androgen--biosynthesis, receptor and action].

Shiina H, Igawa M.

Nihon Rinsho. 1997 Nov;55(11):2860-4. Review. Japanese.

PMID:
9396277
16.

Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection.

Nguyen TV, Yao M, Pike CJ.

J Neurochem. 2005 Sep;94(6):1639-51. Epub 2005 Jul 11.

17.

Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells.

Bagchi G, Wu J, French J, Kim J, Moniri NH, Daaka Y.

Cancer Res. 2008 May 1;68(9):3225-31. doi: 10.1158/0008-5472.CAN-07-5026.

18.

Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion.

Sathya G, Chang CY, Kazmin D, Cook CE, McDonnell DP.

Cancer Res. 2003 Nov 15;63(22):8029-36.

19.

Androgens differentially potentiate mouse intestinal smooth muscle by nongenomic activation of polyamine synthesis and Rho kinase activation.

González-Montelongo MC, Marín R, Gómez T, Díaz M.

Endocrinology. 2006 Dec;147(12):5715-29. Epub 2006 Aug 31.

PMID:
16946014
20.

A physiological role for androgen actions in the absence of androgen receptor DNA binding activity.

Pang TP, Clarke MV, Ghasem-Zadeh A, Lee NK, Davey RA, MacLean HE.

Mol Cell Endocrinol. 2012 Jan 2;348(1):189-97. doi: 10.1016/j.mce.2011.08.017. Epub 2011 Aug 22.

PMID:
21872641

Supplemental Content

Support Center